| pubmed-article:16446329 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16446329 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16446329 | lifeskim:mentions | umls-concept:C0543467 | lld:lifeskim |
| pubmed-article:16446329 | lifeskim:mentions | umls-concept:C0677886 | lld:lifeskim |
| pubmed-article:16446329 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
| pubmed-article:16446329 | lifeskim:mentions | umls-concept:C0677874 | lld:lifeskim |
| pubmed-article:16446329 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
| pubmed-article:16446329 | lifeskim:mentions | umls-concept:C0281548 | lld:lifeskim |
| pubmed-article:16446329 | lifeskim:mentions | umls-concept:C1704788 | lld:lifeskim |
| pubmed-article:16446329 | lifeskim:mentions | umls-concept:C0591833 | lld:lifeskim |
| pubmed-article:16446329 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:16446329 | pubmed:dateCreated | 2006-1-31 | lld:pubmed |
| pubmed-article:16446329 | pubmed:abstractText | This was a multinational, open-label, randomized phase III trial comparing yttrium-90-labeled murine HMFG1 (90Y-muHMFG1) plus standard treatment versus standard treatment alone in patients with epithelial ovarian cancer (EOC) who had attained a complete clinical remission after cytoreductive surgery and platinum-based chemotherapy. | lld:pubmed |
| pubmed-article:16446329 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16446329 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16446329 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16446329 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16446329 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16446329 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16446329 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16446329 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16446329 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16446329 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:16446329 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:16446329 | pubmed:author | pubmed-author:SeidenMichael... | lld:pubmed |
| pubmed-article:16446329 | pubmed:author | pubmed-author:JoblingTomT | lld:pubmed |
| pubmed-article:16446329 | pubmed:author | pubmed-author:StampGordonG | lld:pubmed |
| pubmed-article:16446329 | pubmed:author | pubmed-author:EpenetosAgame... | lld:pubmed |
| pubmed-article:16446329 | pubmed:author | pubmed-author:SoperJohn TJT | lld:pubmed |
| pubmed-article:16446329 | pubmed:author | pubmed-author:MassugerLeon... | lld:pubmed |
| pubmed-article:16446329 | pubmed:author | pubmed-author:SpiegelGregor... | lld:pubmed |
| pubmed-article:16446329 | pubmed:author | pubmed-author:BenignoBenedi... | lld:pubmed |
| pubmed-article:16446329 | pubmed:author | pubmed-author:VerheijenRené... | lld:pubmed |
| pubmed-article:16446329 | pubmed:author | pubmed-author:LopesAlbertoA | lld:pubmed |
| pubmed-article:16446329 | pubmed:author | pubmed-author:MarkowskaJani... | lld:pubmed |
| pubmed-article:16446329 | pubmed:author | pubmed-author:VyzulaRostisl... | lld:pubmed |
| pubmed-article:16446329 | pubmed:author | pubmed-author:ThurstonDenni... | lld:pubmed |
| pubmed-article:16446329 | pubmed:author | pubmed-author:FalkeTheoT | lld:pubmed |
| pubmed-article:16446329 | pubmed:author | pubmed-author:LambertJoanna... | lld:pubmed |
| pubmed-article:16446329 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:16446329 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:16446329 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:16446329 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16446329 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16446329 | pubmed:pagination | 571-8 | lld:pubmed |
| pubmed-article:16446329 | pubmed:dateRevised | 2011-8-1 | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:meshHeading | pubmed-meshheading:16446329... | lld:pubmed |
| pubmed-article:16446329 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16446329 | pubmed:articleTitle | Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission. | lld:pubmed |
| pubmed-article:16446329 | pubmed:affiliation | Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, VU University Medical Center, Amsterdam, The Netherlands. r.verheijen@vumc.nl | lld:pubmed |
| pubmed-article:16446329 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16446329 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16446329 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16446329 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:16446329 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16446329 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16446329 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16446329 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16446329 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16446329 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16446329 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16446329 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16446329 | lld:pubmed |
